Why the study?
This review aimed to outline the link between smoking and hypertension while exploring how smoking interacts with beta-adrenergic antagonists used as antihypertensive drugs.
Does cigarette smoking affect the efficacy of beta-adrenergic antagonists in hypertensive patients?
Does cigarette smoking affect the efficacy of beta-adrenergic antagonists in hypertensive patients?
Smoking alters the pharmacokinetics and pharmacodynamics of beta-blockers in hypertensive patients, highlighting the need for potential dosage adjustments based on smoking status.
Answers are grounded in this paper and cite their sources.
Inconsistent evidence on smoking, hypertension, and beta-blocker interactions warrants clinical caution; leaves open need for rigorous trials.
Cigarette smoking is one of the hypertension risk factors which can adversely affect the quality of life. This review aimed to provide a brief overview of the link between smoking and hypertension. At the same time, raising questions about how smoking interacts with beta-adrenergic antagonists that are used as antihypertensive drugs. By searching for relevant studies through multiple search engines, there is inconsistent evidence about the effect of smoking on high blood pressure. Mainly attributed to the availability of numerous confounding factors. However, cigarette smoking cannot be ignored because smoking exerts dual effects on hypertension as a disease and the treatment with antihypertensive drugs, particularly beta-adrenergic antagonists. The potential drug interaction can occur through pharmacokinetics and pharmacodynamics mechanisms resulting in influencing the efficacy of these drugs. It is necessary to have dosage modifications according to the patient's smoking status, whether in hospitals or outpatient clinics.
No takes yet. Share an insight, caveat, or question.
Hala F. Kasim (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: